alexa Roles of Ionic Environments in Growth of Human Cancer Cell and Potentials of Ion Transporter Blockers in Cancer Therapies | OMICS International
ISSN: 2161-069X
Journal of Gastrointestinal & Digestive System

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Roles of Ionic Environments in Growth of Human Cancer Cell and Potentials of Ion Transporter Blockers in Cancer Therapies

Yoshinori Marunaka1-3*

1Department of Molecular Cell Physiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan

2Department of Bio-Ionomics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan

3Japan Institute for Food Education and Health, Heian Jogakuin (St. Agnes’) University, Kyoto, Japan

Corresponding Author:
Yoshinori Marunaka
Department of Molecular Cell Physiology
Kyoto Prefectural University of Medicine
465 Kajii-cho, Kamigyoku, Kyoto 602-8566, Japan
Tel: +81-75-251-5311
Fax: +81-75-251-0295
E-mail: [email protected]

Received Date: December 09, 2013; Accepted Date: December 30, 2013; Published Date: January 08, 2014

Citation: Marunaka Y (2014) Roles of Ionic Environments in Growth of Human Cancer Cell and Potentials of Ion Transporter Blockers in Cancer Therapies. J Gastroint Dig Syst 3:163. doi: 10.4172/2161-069X.1000163

Copyright: © 2014 Marunaka Y. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Gastrointestinal & Digestive System

Introduction

Cancer cells live in hypoxic, hypo-nutrient circumstances provided by insufficient angiogenesis due to fast rates of cancer cell proliferation [1,2]. These circumstances lead cancer cells via production of ATP as energy sources mainly via high rate glycolysis, while most normal cells produce ATP via oxidation of pyruvate in mitochondria with relatively low-rate glycolysis compared with cancer cells [3]. The high-rate glycolys is forming lactate produces a large amount of H+, providing acidic micro environments around cancer cells [4]. Interestingly, cancer cells keep the cytosolic pH (pHc) slightly higher than that of normal cells even under these environmental conditions provided by a large amount of H+ due to high-rate glycolysis [5,6]. From a viewpoint of cell cycle arrest, apoptosis and cell growth, pHc of tumor cells kept at a level slightly higher than that of normal cells is a key factor for prevention from cell cycle arrest and apoptosis even under acidic microenvironments around cancer cells [7,8]. These findings clearly indicate that cancer cells have to maintain their pHc at a level slightly higher than that of normal cells for survival even under acidic conditions with production of a large amount of H+. For maintenance of pHc at a level slightly higher even under acidic environmental conditions than normal one, expression and/or activity of H+ and/or HCO3 -transporting systems in cancer cells would be expected to be higher than normal cells. Further, it is notable that cancer cells utilize a self-nutrient-recycling autophagy system for their survival even under starvation conditions [9-11]. The self-nutrient-recycling autophagy occurs in lysosome, and the intralysosomal pH is much lower than the cytosolic one [12,13]. Cl-also plays a key role in regulation of pHc and intra-lysosomal pH. In this article, I discuss roles of ionic circumstances in growth and lysosomal function in cancer cells.

Expression of ion transporters regulating pHc in cancer cells

Cancer cells have been reported to express four major ion transporters participating in keeping pHc at a normal or slightly higher level even under acidic environmental conditions than normal one [14- 16]. These four major ion transporters regulating pHc are classified into two categories [14-16]; i) H+ transporters, and ii) HCO3 -transporters. H+ transporters, Na+/H+ exchanger (NHE) and H+ pumps (V-type H+-ATPase, etc.), directly extrude H+from the cytosolic space to the extracellular or into the intra-lysosomal one keeping high pHc. On the one hand, HCO3 -transporters, Na+/HCO3 - cotransporter (NBC), Na+- driven Cl-/HCO3 - exchanger (NDCBE), and Cl-/HCO3 - exchanger (AE), participate in HCO3 - movement across the plasma membrane regulating pHc. Unlike H+ transporters these HCO3 -transporters do not participate in unidirectional transport of HCO3-; i.e., NBC and NDCBE contribute to uptake of HCO3 - into the cytosolic space using the electrochemical gradient of Na+ for elevation of pHc, but AE extrudes HCO3 - from the cytosolic space to the extracellular one for a decrease in pHc instead of elevation of the cytosolic Cl- concentration under general conditions.

Roles of NHE and its Inhibitor in Growth of Cancer Cells and Ionic Circumstances in Cancer Cells

Among the pHc-regulating ion transporters mentioned above, NHE is the major regulator of pHc ubiquitously expressed in most cells including cancer cells, and 10 isoforms of NHEs have been identified [17-21]. NHE1, an isoform of NHE, is the most ubiquitously expressed one among 10 isoforms [22-28]. Various types of growth factors, integlins, tyrosine phosphatases and cytokines regulate activity of NHE1 [22-28]. NHE, in particular NHE1, in cancer cells plays a crucial role in maintenance of pHc at a level slightly higher than normal one [29]. Proliferation and migration of many cancer cells require pHc slightly higher than normal one, which depends on NHE activity [19-21].Therefore, NHE inhibitors should be investigated as anticancer drugs inhibiting proliferation of cancer cells underacidic micro-environmental conditions. Indeed, many researchers have tried to investigate action of NHE inhibitors on proliferation of cancer cells in detail [30]. Recently, we [31] have also reported that 5-(N-ethyl- N-isopropyl) amiloride (EIPA, an NHE inhibitor [32]) inhibits the proliferation of human gastric cancer cells. It is generally thought that inhibition of NHE decreases pHc. However, our report [31] indicates that inhibition of NHE has no influence on pHc, but decreases the cytosolic Cl- concentration ([Cl-]c).The cytosolic Cl- has been reported to play important roles in various cell functions including proliferation of cancer cells [33-48]. The role of cytosolic Cl- in cancer cell proliferation has been also investigated; when [Cl-]c is experimentally decreased by lowering the extracellular Cl- concentration, gastric cancer cells show diminution of cell proliferation via a p53-independent p21- upregulation pathway [36,43]. Thus, the cytosolic Cl- is one of the key regulators in cancer cell proliferation [31] (Figure 1).

gastrointestinal-digestive-system-Ion-transporters

Figure 1: Ion transporters involved in regulation of cytosolic Cl- environments and roles of cytosolic Cl- in cell function. Na+/H+ exchanger (NHE) has no direct contribution to intracellular Cl- environments, since NHE directly participates in Na+ uptake coupling with H+ extrusion. However, application of an inhibitor of NHE, EIPA, lowers the cytosolic Cl- concentration ([Cl-]c) without any effect on cytosolic pH (pHc) [31]. The EIPA-caused lowered [Cl-]c would be due to activation of Na+-driven Cl-/HCO3 - exchanger (NDCBE) compensating the EIPA-caused acute lowered pHc [31]. For example, in cancer cells mitochondria function is low, leading to low production of CO2. This means that contents of H+ and HCO3 - induced by CO2 from mitochondria are low in cytosolic space of cancer cells. On the one hand, cancer cells produce a lot of H+ via glycolysis, being converted to CO2 and H2O with HCO3 - a carbonic anhydrase-mediated process, resulting in lowered HCO3 - in cytosolic space. Taken together, the amount of HCO3 - in cytosolic space of cancer cells is much lower than that in normal cells. Thus, activation of ion transporters taking HCO3 - up into the cytosolic space such as NDCBE, which extrudes cytosolic Cl- using electrochemical gradient of Na+, in cancer cells with a low HCO3 - condition is much effective in lowering [Cl-]c than normal cells. Namely, inhibition of NHE and activation of NDCBE would effectively decrease [Cl-]c, under a condition with low mitochondria function occurring in cancer cells. This leads cancer cells to G0/G1 arrest via a MPKs-p21-Rb pathway and autophagy dysfunction via elevation of intra-lysosomal pH. Based on the information described above, some drugs modifying activity of ion transporters involved in regulation of cytosolic Cl- environments would be useful for anticancer therapies. AE, Cl-/HCO3 - exchanger; ClC-7, 2Cl-/1H+ exchange; MPKs, mitogen-activated protein kinases; NBC, Na+-HCO3 - cotransporter; NDCBE, Na+-driven Cl-/HCO3 - exchanger; NHE, Na+/H+ exchanger; NKCC, Na+-K+-2Cl- cotransporter; Rb, retinoblastoma protein; V-ATPase, V-type H+-ATPase.

Autophagy in Cancer Cells

Cells survive even under starvation conditions utilizinga selfnutrient- recycling autophagy system [9-11]. Cells check if they should degrade long-lived or miss-folded proteins, and damaged organelles such as mitochondria utilizing this autophagy system [49-51]. The autophagy system is induced by starvation-caused poverty of nutrients, mainly amino acids, for cells to survive utilizing reproduced nutrients originally contained in cells themselves [9]. Recycled amino acids reproduced by autophagy are utilized for new proteins synthesis [9]. Autophagy is generally activated by starvation, however autophagy process functions even under conditions with rich nutrition [52]. Activity of autophagy is closely correlated with not only cancer [53], but also other diseases such as diabetes mellitus [54], Parkinson disease [51], and inflammatory disease, Crohn disease [55].

Autophagy and Intra-Lysosomal Ionic Circumstances in Cancer Cells

Autophagy ability in cancer cells is much higher than normal cells, since cancer cells have to survive under hypoxic, hypo-nutrient micro environments utilizing recyclable nutrition such as amino acids [53]. It has been reported that Atg5 or Atg7 plays a key role in autophagy function; lack of Atg5 or Atg7 impairs the autophagy system and apoptosis in cancer cells [56-58]. Lysosomal machineries catabolize cell components, indicating that lysosome is a key organelle producing autophagy function in degradation of various compounds [11]. It is well known that the intra-lysosomal pH is lower than pHc [12,13], and that this lower intra-lysosomal pH is a key factor to maintain the digesting activity of lysosomal enzymes; i.e., lysosomal enzymes require low pH to maintain their enzymatic activities [59]. The V-type H+-ATPase (proton pump) generates the intra-lysosomal low pH cooperating with ClC-7located on the lysosome membrane [60,61]. ClC- 7has stoichiometry of 2Cl-/1H+ exchange, and is assumed to primarily behave as a Cl- permeation pathway across the lysosomal membrane [60], although there is still some contradictory observations (e.g., [62]). Mutation of ClC-7 impairs lysosomal function, which is detected as abnormal accumulation of proteins into the intra-lysosomal space [63], meaning that the function of ClC-7 as a Cl- permeation pathway would contribute to lysosomal function (protein degradation) via maintenance of low intra-lysosomal pH. Further, knock down of ClC- 7 impairs lysosomal acidification [60], and inhibits cell proliferation associated with abnormal accumulation of proteins in lysosomes [64]. These studies [60,63,64] suggest that ClC-7 would be essential as Clmovement/ transport for maintenance of low intra-lysosomal pH and autophagy-dependent cell proliferation. Although these studies [60,63,64] suggest the importance of Cl- movement/transport via ClC- 7, the importance of functional presence of Cl-is not confirmed. Our study suggests that the presence of Cl- itself plays an essential role in autophagy (Figure 1).

Conclusion

Some drugs modifying activity of ion transporters involved in cytosolic Cl- environments would be useful for anticancer therapies (Figure 1).

Acknowledgements

This work was supported by Grants-in-Aid from Japan Society of the Promotion of Science (25670111), Fuji Foundation for Protein, Research Conference for Cell Function, and The Salt Science Research Foundation (1235).

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 11767
  • [From(publication date):
    December-2013 - Jun 23, 2018]
  • Breakdown by view type
  • HTML page views : 7993
  • PDF downloads : 3774
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7